NCT02191462View on ClinicalTrials.gov

A Study of the Pharmacokinetics of Three Dosages of Niagen in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions

Pharmacokinetics

Interventions

DIETARY_SUPPLEMENT

Niagen 100mg

DIETARY_SUPPLEMENT

Niagen 300mg

DIETARY_SUPPLEMENT

Niagen 1000mg

Trial Locations (1)

N6A 5R8

KGK Synergize Inc., London

Sponsors

Lead Sponsor

KGK Science Inc.

All Listed Sponsors

collaborator

ChromaDex, Inc.

INDUSTRY

lead

KGK Science Inc.

INDUSTRY